Family · Pharmaceutical analytical standards
Tamsulosin
An alpha blocker that relaxes the smooth muscle of the prostate and bladder neck, making urination easier: developed in Japan, introduced there in 1993 and approved in the US in 1997 for benign prostatic hyperplasia. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It favours the alpha-1 receptor subtype that dominates in the human prostate: even in early tests it selectively lowered pressure in the prostatic urethra.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
